SpringWorks CEO Saqib Islam (L) and COO Badreddin Edris
SpringWorks fixes 'minor data handling error' after March Form 483 for trial site linked to upcoming PDUFA
The FDA issued SpringWorks Therapeutics a Form 483 on March 31, saying that the company’s own clinical trial protocols were not followed.
But SpringWorks COO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.